Last reviewed · How we verify

A. Paniculata — Competitive Intelligence Brief

A. Paniculata (A. Paniculata) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Herbal extract / Botanical immunomodulator. Area: Immunology / Respiratory / Infectious Disease.

phase 3 Herbal extract / Botanical immunomodulator Immunology / Respiratory / Infectious Disease Small molecule Live · refreshed every 30 min

Target snapshot

A. Paniculata (A. Paniculata) — Vedic Lifesciences Pvt. Ltd.. Andrographis paniculata extract enhances immune function and reduces inflammatory markers through multiple phytochemical constituents.

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
A. Paniculata TARGET A. Paniculata Vedic Lifesciences Pvt. Ltd. phase 3 Herbal extract / Botanical immunomodulator
Ginseol Kg1(high dose) Ginseol Kg1(high dose) Seoul National University Hospital phase 3 Herbal extract / Botanical immunomodulator

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Herbal extract / Botanical immunomodulator class)

  1. Seoul National University Hospital · 1 drug in this class
  2. Vedic Lifesciences Pvt. Ltd. · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). A. Paniculata — Competitive Intelligence Brief. https://druglandscape.com/ci/a-paniculata. Accessed 2026-05-15.

Build your own brief

Pick any drug + add comparators: